Théa Laboratories
Manufacturing · France · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
12 Rue Louis Bleriot, Clermont-Ferrand, ...Phone Number
+33 473981436Website
www.laboratoires-thea.comRevenue
$909.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
3
3
1
1
1
1
About Théa Laboratories
Théa is the leading independent European pharmaceutical group in ophthalmology. Based in Clermont-Ferrand, France, it has thirty-five affiliates & offices in Europe, North and South America, North Africa, and the Middle East. Today, its network includes nearly 1,500 employees, and its products are available in 75 countries around the world. In 2021, Théa had global revenues of approximately $773 million. The independent and family-owned and run group, founded from a Research and Development start-up by Henri Chibret, has been chaired since 2008 by Jean-Frédéric Chibret, his nephew.Explore more
Théa Laboratories Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Théa Laboratories your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Product Launch: Get notified when Théa Laboratories launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Funding: Get notified immidiatlly once Théa Laboratories has new funding data
Check if Théa Laboratories has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Théa Laboratories recently announced quarterly report
Click to see if Théa Laboratories had a recent Job posting/layoffs
Théa Laboratories, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Théa Laboratories
Check out if Théa Laboratories is spiking on competitors!
Recommended Actions
Find VP level buyers at Théa Laboratories
Find more new buyers
Company Profile Activity
Activity Insights
Théa Laboratories is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Théa Laboratories is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Théa Laboratories.
Théa Laboratories Tech Stack
A closer look at the technologies used by Théa Laboratories
See more technologies
Théa Laboratories News & Media
Iolyx Therapeutics Enters Strategic Agreement with Laboratoires Théa to Develop and Commercialize ILYX-002 intended for the Treatment of Autoimmune Associated Dry Eye Disease and Secures Series B Funding for Retinal Pipeline
Deal with Laboratoires Théa representing a total value of up to $280 million including clinical, regulatory and commercial conditional milestones, commercial royalties, and development responsibility for Phase 3 trialsLaboratoires Thea Selects Ivalua's Platform and Fluxym's Methodology for Supplier Management and Sourcing
REDWOOD CITY, Calif., Jan. 9, 2025 /PRNewswire/ -- Ivalua, a global leader in spend management, and its partner integrator Fluxym, today announced that Laboratoires Théa (Théa) has selected the Ivalua platform to manage its supplier repository, digitize its sourcing processes and automate...Novaliq and Laboratoires Théa Announce Partnership and EU Approval for Vevizye® (Ciclosporin 0.1% Eye Drops Solution)
HEIDELBERG, Germany & CAMBRIDGE, Mass. & CLERMONT-FERRAND, France--(BUSINESS WIRE)-- #CHMP--Novaliq, a biopharmaceutical company focusing on first- and best-in-class ocular therapeutics based on the unique EyeSol® water-free technology, and Laboratoires Théa (Théa), the leading independent eye care group in Europe, announce European Commission approval of Vevizye® (ciclosporin 0.1% eye drops solution) in Europe and the closing of a partnership under which Théa has acquired the rights to commerciProQR Therapeutics and Laboratoires Théa Announce Agreement for Théa to Acquire ProQR’s Sepofarsen and Ultevursen Ophthalmic Assets
Agreement provides ProQR with initial payment of €12.5M and up to €135M in further payments, as well as potential additional earn outs based on commercial sales in the US and EU
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Théa Laboratories
Sign Up For FreeTo access detailed company insights
Théa is the leading independent European pharmaceutical group in ophthalmology. Based in Clermont-Ferrand, France, it has thirty-five affiliates & offices in Europe, North and South America, North Africa, and the Middle East. Today, its network includes nearly 1,500 employees, and its products are available in 75 countries around the world. In 2021... Read More
